By targeting two receptors, it produced an average weight loss of approximately 22.5% in clinical trials, which is significantly greater than the roughly 15% typically seen with semaglutide
In addition, they exhibit significant side effects and addiction issues during long-term use
The medication isnt typically intended as a short-term solution
Do GLP-1 receptor agonists have cardiovascular benefits
+Commonly discussed benefits Soft-tissue repair: tendons, ligaments, muscle strains Gut-lining support and discussion in IBS/IBD research Joint comfort during heavy training blocks Often-discussed neuroprotective effects in animal models +Research highlights Extensive animal research from the Zagreb group and others supports BPC-157's tissue-repair profile across tendon, ligament, gut, muscle, bone, and even cardiovascular models